Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Maciej Banach"'
Autor:
Sahebkar A, Serban C, Ursoniu S, Mikhailidis DP, Undas A, Lip GY, Bittner V, Ray K, Watts GF, Hovingh GK, Rysz J, Kastelein JJ, Banach M; Prof. Maciej Banach, MD, PhD, FNLA, FAHA, FESC; FASA, Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland, Tel.: +48 42 639 37 71, Fax: +48 42 639 37 71, E-mail: maciejbanach@aol.co.uk.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2016 Mar; Vol. 115 (3), pp. 520-32. Date of Electronic Publication: 2015 Dec 03.
Autor:
Sahebkar A, Serban C, Mikhailidis DP, Undas A, Lip GY, Muntner P, Bittner V, Ray KK, Watts GF, Hovingh GK, Rysz J, Kastelein JJ, Banach M; Prof. Maciej Banach, MD, PhD, FNLA, FAHA, FESC; FASA, Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113; 90-549 Lodz, Poland, Tel.: +48 42 639 37 71, Fax: +48 42 639 37 71, E-mail: maciejbanach@aol.co.uk.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2015 Aug 31; Vol. 114 (3), pp. 546-57. Date of Electronic Publication: 2015 May 28.
Publikováno v:
Current Atherosclerosis Reports. 24:791-801
Purpose of Review The aim of creating an orally active non-statin cholesterol-lowering drug was achieved with bempedoic acid, a small linear molecule providing both a significant low-density lipoprotein cholesterol (LDL-C) reduction and an anti-infla
Are statins beneficial in patients with vasospastic angina? A meta-analysis of observational studies
Publikováno v:
Progress in Cardiovascular Diseases. 73:88-90
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-14 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
The global coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 coronavirus started in March 2020. The conclusions from numerous studies indicate that people with comorbidities, such as arterial hypertension, diabetes, obesity, under
Autor:
Amirhossein Sahebkar, Paul C. Guest, Amir Vahedian-Azimi, Farshad Heidari Beni, Khalid Al-Rasadi, Tannaz Jamialahmadi, Seyede Momeneh Mohammadi, Maciej Banach
Publikováno v:
BioMed Research International, Vol 2021 (2021)
BioMed Research International
BioMed Research International
Background. Although vaccine rollout for COVID-19 has been effective in some countries, there is still an urgent need to reduce disease transmission and severity. We recently carried out a meta-analysis and found that pre- and in-hospital use of stat
Autor:
J. Wouter Jukema, Peter P. Toth, Gregory Y.H. Lip, Mahmoud Mohamed Zaki, Maciej Banach, Abdelrahman Ibrahim Abushouk, Michael J. Blaha, Naveed Sattar, Maged Mohammed, Kamal Awad, Carl J. Lavie
Publikováno v:
BMC Medicine, Vol 19, Iss 1, Pp 1-17 (2021)
BMC Medicine, 19(1). BMC
BMC Medicine
BMC Medicine, 19(1). BMC
BMC Medicine
Background Current evidence from randomized controlled trials on statins for primary prevention of cardiovascular disease (CVD) in older people, especially those aged > 75 years, is still lacking. We conducted a systematic review and meta-analysis of
Autor:
Tadeusz Osadnik, Marcin Goławski, Piotr Lewandowski, Jakub Morze, Kamila Osadnik, Natalia Pawlas, Mateusz Lejawa, Grzegorz K. Jakubiak, Agnieszka Mazur, Lucas Schwingschackl, Mariusz Gąsior, Maciej Banach
Publikováno v:
Pharmacological research. 183
It is estimated that 2.6 million deaths worldwide can be attributed to hypercholesterolemia. The main reason for non-adherence to statin therapy are the statin-associated muscle symptoms (including nocebo/drucebo effect). In this case, apart from eze
Autor:
Joanna Lewek, Maciej Banach
Publikováno v:
Current atherosclerosis reportsPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 24(7)
Despite the elevation of lipid values during pregnancy is mostly physiological, evidence suggest that it may be associated with adverse events. This article reviews the characteristics of lipid disorders and the possible management with dyslipidemia
Publikováno v:
Journal of the American College of Cardiology. 77:620-628
The extract of red yeast rice (RYR) is the most effective cholesterol-lowering nutraceutical on the market. In particular, its effectiveness is directly related to the amount of monacolin K within the extract (up to 10 mg/day). Consuming monacolin K